- $1.23bn
- $659.30m
- $168.34m
- 62
- 28
- 61
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 157 | 123 | 275 | 165 | 168 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 143 | 199 | 232 | 247 | 307 |
Operating Profit | 13.8 | -76.8 | 43 | -82.6 | -139 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 27.2 | -69.3 | 82.6 | -54.5 | -120 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.9 | -69.3 | 82.6 | -55.2 | -126 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.9 | -69.3 | 82.6 | -55.2 | -126 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.9 | -69.3 | 82.6 | -55.2 | -126 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.46 | -1.21 | 1.38 | -0.924 | -2.07 |